X
Archive by tag: Wilson Sonsini Goodrich & RosatiReturn

Delaware Court of Chancery Addresses Significant Issues Regarding Private Company Deal Litigation

On May 15, 2019, Vice Chancellor Slights of the Delaware Court of Chancery issued a ruling addressing important issues related to private company deal litigation. Specifically, the decision addressed when a release of claims and covenant not to sue...By: Wilson Sonsini Goodrich & Rosati
Read More

FDA Suspends Facility Registration of Texas-Based Seafood Producer

On July 22, 2019, the U.S. Food and Drug Administration (FDA) suspended the food facility registration of Topway Enterprises Inc.'s (Topway) Houston, Texas seafood processing facility. As a result, Topway cannot sell or distribute any food into...By: Wilson Sonsini Goodrich & Rosati
Read More

FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues

Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...By: Wilson Sonsini Goodrich & Rosati
Read More

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues - July 2019 #2

Legislation - Consumer Product Safety: House Committee Approves Six Bills - Responding to what they claim has been a failure of the Consumer Product Safety Commission (CPSC) to act in recent years, the House Energy and Commerce Committee adopted...By: Wilson Sonsini Goodrich & Rosati
Read More

Modernizing EU Competition Policy: Will the EU's Angst with Chinese State-Owned Companies Help U.S. Tech Firms off the European Commission's Hook?

During her five-year term as European commissioner for competition, Margrethe Vestager has earned a reputation for going hard after U.S. tech companies. This position had traction in certain European political circles and, with the support of the...By: Wilson Sonsini Goodrich & Rosati
Read More

Another Shot Across the Bows: EC Levies $32 Million Gun-Jumping Fine on Canon

As the time taken to secure merger control clearances for global transactions lengthens, the parties and their advisers may be tempted to explore alternative deal structures that might allow a transaction to close sooner than otherwise expected. In a...By: Wilson Sonsini Goodrich & Rosati
Read More

Delaware Court of Chancery Allows Claims Against a Board, Financial Advisor, and Acquiror in a Company Sale

On June 21, 2019, Vice Chancellor Kathaleen S. McCormick of the Delaware Court of Chancery issued an opinion addressing a number of significant issues relating to the proper conduct of an M&A process. In denying all defendants' motions to dismiss,...By: Wilson Sonsini Goodrich & Rosati
Read More

The Life Sciences Report - Summer 2019

Navigating the U.S. Healthcare Regulatory Landscape for Wearable Devices - Complex Environment Includes Key Federal Agencies FDA, FTC, OCR, CPSC, CMS, and OIG - The wearable device market is emerging as a key player in big data and digital...By: Wilson Sonsini Goodrich & Rosati
Read More

FDA Signals a Deliberative Approach to Cannabis at Public Hearing

While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...By: Wilson Sonsini Goodrich & Rosati
Read More

Delaware Court Addresses Treatment of Sellers' Attorney-Client Privilege in Merger

Last week, Vice Chancellor Kathaleen S. McCormick of the Delaware Court of Chancery issued a decision, Shareholder Representative Services LLC v. RSI Holdco, LLC, addressing when a selling company's attorney-client privilege relating to the sale of...By: Wilson Sonsini Goodrich & Rosati
Read More
Page 3 of 3 [3] NextLast